Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
Fixed Capital/Sales

    Back to All Ratios
TRIDENT LIFELINE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

TRIDENT LIFELINE Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.460.310.100.10

What is the latest Fixed Capital/Sales ratio of TRIDENT LIFELINE ?

The latest Fixed Capital/Sales ratio of TRIDENT LIFELINE is 0.46 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.46
Mar20240.31
Mar20230.10
Mar20220.10

How is Fixed Capital/Sales of TRIDENT LIFELINE Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.46
48.39
Mar2024 0.31
210.00
Mar2023 0.1
0.00
Mar2022 0.1 -

Other Financial Ratios of TRIDENT LIFELINE


Compare Fixed Capital/Sales ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹312.8 Cr -0.8% -13.5% -11.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

-0.8%

-13.5%

-11.7%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses